<DOC>
	<DOCNO>NCT00676832</DOCNO>
	<brief_summary>The purpose study determine whether COLAL-PRED safe effective treatment patient moderate severe ulcerative colitis .</brief_summary>
	<brief_title>Study COLAL-PRED Treat Moderate Severe Ulcerative Colitis</brief_title>
	<detailed_description>This multi-center , randomize , double-blind , placebo-controlled , parallel-design , dose-ranging study . Eligible patient DAI score 6 10 ( inclusive ) , plus endoscopic evidence moderate severe ulcerative colitis assess flexible sigmoidoscopy , unless colonoscopy clinically indicate , rectal bleeding randomize placebo one four dose COLAL-PRED ( equivalent 40 , 60 , 80 , 120 mg prednisolone ) . The effectiveness safety COLAL-PRED evaluate baseline , 2 week 4 week treatment . Additional follow-up measurement take place 7 day post cessation treatment . The systemic absorption COLAL-PRED determine measure blood level prednisolone , prednisolone sodium metasulfobenzoate ( PMSBS ) metasulfobenzoate Week 4 . Hypothalamic-pituitary-adrenocortical ( HPA ) axis response monitor measure morning serum cortisol level Baseline , Week 2 , Week 4 , follow-up visit cortisol level follow adrenocorticotrophic hormone ( ACTH ) stimulation test Baseline Week 4 .</detailed_description>
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Colitis , Ulcerative</mesh_term>
	<mesh_term>Colitis</mesh_term>
	<mesh_term>Prednisolone acetate</mesh_term>
	<mesh_term>Methylprednisolone acetate</mesh_term>
	<mesh_term>Prednisolone</mesh_term>
	<mesh_term>Methylprednisolone</mesh_term>
	<mesh_term>Methylprednisolone Hemisuccinate</mesh_term>
	<mesh_term>Prednisolone hemisuccinate</mesh_term>
	<mesh_term>Prednisolone phosphate</mesh_term>
	<criteria>Females must nonchildbearing potential evidence surgically sterile , postmenopausal least 12 month use acceptable contraception method contraceptive pill , two form barrier contraception . Disease Activity Index ( DAI ) Score 610 ( inclusive ) Baseline Visit . Previous colonoscopic biopsy diagnosis ulcerative colitis negative evaluation ileum within 3 year screen visit . Endoscopic evidence moderate severe mucosal disease assess flexible sigmoidoscopy , minimum confirm diagnosis moderate ulcerative colitis . The following concomitant prescription medication ulcerative colitis permit follow condition meet : 1 . Oral 5aminosalicylic acid ( 5ASA ) therapy follow 2 criterion meet : 1 . Must stable dose 2 week prior baseline 2 . Must maintain stable dose treatment end . 2 . Azathioprine 6mercaptopurine methotrexate 4 follow criterion meet : 1 . On therapy continually least 3 month prior baseline . 2 . And stable dose least 2 week prior baseline . 3 . And must maintain stable dose end study drug treatment . History colonic rectal surgery , exclude hemorrhoidal surgery appendectomy . Pregnant breastfeeding female . Diagnosis diabetes , heart failure , unstable angina , hepatic cirrhosis , kidney failure , adrenocortical insufficiency , unstable medical condition . Known hypersensitivity corticosteroid Use oral 5aminosalicylic acid ( 5ASA ) oral corticosteroid immediate screening period . Use immunosuppressive drug antibiotic time within four week prior screen . Diagnosis Crohn 's disease ; indeterminate colitis ; microscopic colitis ; ischemic , infectious ( e.g. , salmonella , shigella , etc . ) , amebic colitis ; gonococcal proctitis ; Clostridium difficile colitis . History tuberculosis HIV Clinically significant abnormal laboratory test result , unless regard Investigator related ulcerative colitis History alcohol drug abuse Known malignancy history malignancy would reduce life expectancy Recent immunization live viral vaccine History active peptic ulcer disease gastritis Generalized infection systemic fungal hepatitis B C History steroid induce severe hypertension , steroidinduced psychosis , severe steroidrelated adverse reaction</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>September 2010</verification_date>
	<keyword>colitis</keyword>
	<keyword>ulcerative</keyword>
	<keyword>moderate</keyword>
	<keyword>severe</keyword>
</DOC>